Literature DB >> 3295878

Functional characterization of an antigen involved in an early step of T-cell activation.

M E Cosulich, A Rubartelli, A Risso, F Cozzolino, A Bargellesi.   

Abstract

An activation antigen, identified by the monoclonal antibody MLR3, is described that is present on activated T lymphocytes and thymocytes but not on resting T lymphocytes. Immunoprecipitation of radiolabeled membranes from an activated T-cell line showed that the MLR3-binding molecule has a molecular size of 28-34 kDa. Immunofluorescence analysis showed that the appearance of the MLR3 antigen is an early event and precedes that of the interleukin 2 receptor both in T lymphocytes and thymocytes. The proliferative response of resting T cells to OKT3-Sepharose and interleukin 1 or accessory cells, but not the interleukin 2-dependent proliferation, was inhibited by the addition of MLR3 monoclonal antibodies. Similar results wer also obtained in an interleukin 1-dependent human thymocyte proliferation assay. In addition when MLR3-positive cells were cultured with purified interleukin 1, MLR3 surface antigen expression was not observed. Thus MLR3 monoclonal antibody appears to recognize an antigen involved in an early step of T-cell activation related to interleukin 1-dependent functions and on both T lymphocytes and thymocytes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3295878      PMCID: PMC305053          DOI: 10.1073/pnas.84.12.4205

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Role of protein and RNA synthesis in the development of insulin binding sites on activated thymus-derived lymphocytes.

Authors:  J H Helderman; T B Strom
Journal:  J Biol Chem       Date:  1979-08-10       Impact factor: 5.157

3.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells.

Authors:  T Uchiyama; D L Nelson; T A Fleisher; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

4.  Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes.

Authors:  B F Haynes; M E Hemler; D L Mann; G S Eisenbarth; J Shelhamer; H S Mostowski; C A Thomas; J L Strominger; A S Fauci
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

5.  Properties of a specific interleukin 1 (IL 1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL 1-alpha and IL 1-beta.

Authors:  K Matsushima; T Akahoshi; M Yamada; Y Furutani; J J Oppenheim
Journal:  J Immunol       Date:  1986-06-15       Impact factor: 5.422

6.  Two distinct factors are required for induction of T-cell growth.

Authors:  E L Larsson; N N Iscove; A Coutinho
Journal:  Nature       Date:  1980-02-14       Impact factor: 49.962

7.  Characterization of a monoclonal antibody that defines an immunoregulatory T cell subset for immunoglobulin synthesis in humans.

Authors:  B F Haynes; D L Mann; M E Hemler; J A Schroer; J H Shelhamer; G S Eisenbarth; J L Strominger; C A Thomas; H S Mostowski; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

8.  Production of lymphocyte-activating factor (Interleukin 1) by macrophages activated with colony-stimulating factors.

Authors:  R N Moore; J J Oppenheim; J J Farrar; C S Carter; A Waheed; R K Shadduck
Journal:  J Immunol       Date:  1980-09       Impact factor: 5.422

9.  Surface antigens specifically expressed by activated T cells in humans.

Authors:  G Corte; L Moretta; G Damiani; M C Mingari; A Bargellesi
Journal:  Eur J Immunol       Date:  1981-02       Impact factor: 5.532

10.  The functional relationship of the interleukins.

Authors:  K A Smith; L B Lachman; J J Oppenheim; M F Favata
Journal:  J Exp Med       Date:  1980-06-01       Impact factor: 14.307

View more
  32 in total

1.  Variation of bronchoalveolar lymphocyte phenotypes with age in the physiologically normal human lung.

Authors:  K C Meyer; P Soergel
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Constitutive expression of CD69 in interspecies T-cell hybrids and locus assignment to human chromosome 12.

Authors:  C Cambiaggi; M T Scupoli; T Cestari; F Gerosa; G Carra; G Tridente; R S Accolla
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

Review 3.  Surface proteins and glycoproteins of human leucocytes.

Authors:  V Horejsí; V Bazil
Journal:  Biochem J       Date:  1988-07-01       Impact factor: 3.857

4.  Expression of a gp33/27,000 MW activation inducer molecule (AIM) on human lymphoid tissues. Induction of cell proliferation on thymocytes and B lymphocytes by anti-AIM antibodies.

Authors:  P Sánchez-Mateos; M Cebrián; A Acevedo; M López-Botet; M O De Landázuri; F Sánchez-Madrid
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

5.  Early lymphocyte activation molecule defined by the monoclonal antibody MLR-3: biochemical and functional studies.

Authors:  D Delia; C Traversari; D Ballinari; G Cattoretti; E Fontanella; N Polli; G Della Porta
Journal:  Immunology       Date:  1988-08       Impact factor: 7.397

6.  CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis.

Authors:  David Sancho; Manuel Gómez; Fernando Viedma; Enric Esplugues; Mónica Gordón-Alonso; María Angeles García-López; Hortensia de la Fuente; Carlos Martínez-A; Pilar Lauzurica; Francisco Sánchez-Madrid
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

7.  Coexpression of Fc gamma receptor IIIA and interleukin-2 receptor beta chain by a subset of human CD3+/CD8+/CD11b+ lymphocytes.

Authors:  S Zupo; L Azzoni; R Massara; A D'Amato; B Perussia; M Ferrarini
Journal:  J Clin Immunol       Date:  1993-05       Impact factor: 8.317

8.  Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.

Authors:  P Vandenberghe; J Verwilghen; F Van Vaeck; J L Ceuppens
Journal:  Immunology       Date:  1993-02       Impact factor: 7.397

9.  A potent and selective small-molecule inhibitor for the lymphoid-specific tyrosine phosphatase (LYP), a target associated with autoimmune diseases.

Authors:  Yantao He; Sijiu Liu; Ambili Menon; Stephanie Stanford; Emmanuel Oppong; Andrea M Gunawan; Li Wu; Dennis J Wu; Amy M Barrios; Nunzio Bottini; Andrew C B Cato; Zhong-Yin Zhang
Journal:  J Med Chem       Date:  2013-06-06       Impact factor: 7.446

10.  Evaluating effects of tyrosine phosphatase inhibitors on T cell receptor signaling.

Authors:  Souad Rahmouni; Laurence Delacroix; Wallace H Liu; Lutz Tautz
Journal:  Methods Mol Biol       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.